HCT - In A Nutshell - KJ, page-466

The SKN dilemma had also crossed my mind with HCT and Invishield. Invishield is now waiting for it's TGA approval. No doubt there are Q&A's between ASIC to SKN via legals and who knows what other authority/ies.

We can only assume that HCT is more than arms length from any SKN with any product association into the SKN funding drama BUT situations like this can become murky for even a benign reason.

This discussion is all speculation and there maybe nothing in it but the silence from our HQ is deafening and this is exactly why there has to be leadership in times of rumours and innuendo so as to cast aside any doubt and provide confidence to your investors.